Author(s): Mary Priya, Treesa P. Varghese, Abilash Vijayan, K. Elango, Anish John

Email(s): treesapv510@gmail.com

DOI: 10.52711/0974-360X.2024.00913   

Address: Mary Priya1, Treesa P. Varghese2, Abilash Vijayan3, K. Elango4, Anish John5
1Associate Professor, Department of Pharmacy Practice, Karpagam College of Pharmacy, Coimbatore, Tamil Nadu, India.
2Associate Professor, Department of Pharmacy Practice, Yenepoya Pharmacy College and Research Centre, (Yenepoya Deemed to be University), Narigana, Mangalore. Karnataka, India.
3Associate Professor, Department of Pharmacy Practice, Dr. Joseph Mar Thomma Institute of Pharmaceutical Science and Research, Alappuzha, Kerala, India.
4Professor, Department of Pharmacy, Faculty of Pharmacy, Karpakam Academy of higher education, Tamil Nadu, India.
5Assistant Professor, Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 12,     Year - 2024


ABSTRACT:
The intricate interplay between gut microbiota and metabolic disorders has sparked interest in exploring probiotics as potential therapeutic agents for Polycystic Ovary Diseases (PCOD). It is a hormonal or endocrine disorder which is a combination of biochemical and clinical including an imbalance in reproductive hormones especially elevated androgen levels (male hormones) called hyperandrogenism. PCOD, also known as PCOS (Polycystic Ovary Syndrome). The endocrine disruption in PCOS can affect the menstrual cycle, ovulation, and other aspects of reproductive and metabolic health. The precise origin and development of this disease are not well understood, but it is believed that a multifaceted interplay involving external factors, surrounding conditions, hormone mediated factors, genetic susceptibility, social and financial status, toxic exposure, psychological stress, Sedentary lifestyle and eating habits are presumed to be the primary ethiopathogenic determinant. A regular exercise program and a diet free of fats and sugars are also recommended to all women with PCOS in order to manage the condition. In recent years, researchers have increasingly examined the gut microbiota and its positive impact on nutritional, immunological and metabolic functions in the host. The involvement of the gut microbiome in various metabolic complications linked to PCOS, such as impaired insulin action, excessive body weight, adiposity and systemic inflammatory status suggests its potential influence on the development of PCOS. Studies reveal that the gut microbiome of women with polycystic ovarian syndrome differs from that of healthy women. Interest in the relationship between gut health and PCOS has grown, and new studies suggest that the development of PCOS related symptoms may be connected to the gut microbiota. Probiotics are live bacteria that, when consumed in sufficient amounts, offer health benefits to the host. As such, they have been investigated for their potential to treat polycystic ovarian syndrome. Probiotic supplementation results in a significant decrease in free androgen index and malondialdehyde levels, along with an increase in nitric oxide and Sex Hormone Binding Globulin (SHBG). It also has an advantage of reduction in body weight and body mass index, hypertrichosis, HOMA-IR and total testosterone levels of PCOS patients. However, it is essential to highlight that studies in this area are still in their infancy, and further research is necessary to provide conclusive proof. The purpose of this review is to evaluate the importance of probiotic supplements in management PCOS symptoms.


Cite this article:
Mary Priya, Treesa P. Varghese, Abilash Vijayan, K. Elango, Anish John. Probiotics as potential allies in hormonal harmony and metabolic management: unlocking the Gut- Poly Cystic Ovary Syndrome (PCOS). Research Journal Pharmacy and Technology. 2024;17(12):6015-9. doi: 10.52711/0974-360X.2024.00913

Cite(Electronic):
Mary Priya, Treesa P. Varghese, Abilash Vijayan, K. Elango, Anish John. Probiotics as potential allies in hormonal harmony and metabolic management: unlocking the Gut- Poly Cystic Ovary Syndrome (PCOS). Research Journal Pharmacy and Technology. 2024;17(12):6015-9. doi: 10.52711/0974-360X.2024.00913   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-12-50


REFERENCES:
1.    Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. J Endocr Soc. 2019; Jun 14; 3(8): 1545-1573. doi: 10.1210/js.2019-00078.
2.    Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016; Oct; 37(5): 467-520. doi: 10.1210/er.2015-1104.
3.    Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J Clin Med. 2023; Feb 11; 12(4): 1454. doi: 10.3390/jcm12041454.
4.    Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015; May; 28(2): 116-20. doi: 10.2337/diaspect.28.2.116.
5.    Davis CD. The Gut Microbiome and Its Role in Obesity. Nutr Today. 2016; Jul-Aug; 51(4): 167-174. doi: 10.1097/NT.0000000000000167.
6.    Amara AA, Shibl A. Role of Probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm J. 2015; Apr; 23(2): 107-14. doi: 10.1016/j.jsps.2013.07.001.
7.    Angoorani P, Ejtahed HS, EttehadMarvasti F, Taghavi M, Mohammadpour Ahranjani B, Hasani-Ranjbar S, Larijani B. The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews. Front Med (Lausanne). 2023; Jun 9; 10: 1141355. doi: 10.3389/fmed.2023.1141355.
8.    Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015; Apr 2; 16(4): 7493-519. doi: 10.3390/ijms16047493.
9.    Bell V, Ferrao J, Pimentel L, Pintado M, Fernandes T. One Health, Fermented Foods, and Gut Microbiota. Foods. 2018; Dec 3; 7(12): 195. doi: 10.3390/foods7120195.
10.    Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017; May 16; 474(11): 1823-1836. doi: 10.1042/BCJ20160510.
11.    Veena Kirthika S, Jibi Paul, Senthil Selvam. P, Sathya Priya. V. Effect of Aerobic exercise and life style intervention among young women with Polycystic Ovary Syndrome. Research J. Pharm. and Tech. 2019; 12(9): 4269-4273. doi: 10.5958/0974-360X.2019.00734.0
12.    Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013; Jan; 6(1): 39-51. doi: 10.1177/1756283X12459294.
13.    Mancin Stefano, Mazzoleni Beatrice. Probiotics as adjuvant therapy in the treatment of Allergic Rhinitis. Research Journal of Pharmacy and Technology. 2023; 16(5): 2393-8. doi: 10.52711/0974-360X.2023.00394
14.    Chen Y, Xu J, Chen Y. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients. 2021; Jun 19; 13(6): 2099. doi: 10.3390/nu13062099.
15.    Averina OV, Zorkina YA, Yunes RA, Kovtun AS, Ushakova VM, Morozova AY, Kostyuk GP, Danilenko VN, Chekhonin VP. Bacterial Metabolites of Human Gut Microbiota Correlating with Depression. Int J Mol Sci. 2020; Dec 3; 21(23): 9234. doi: 10.3390/ijms21239234.  
16.    Putri Ramadhani, Suharjono, IswinarnoDosoSaputro, Ria Fitrah Arfiani, UlfaSyafli Nosa. Scoping Review: Effects of Probiotics against The Immune System in Burn patients. Research Journal of Pharmacy and Technology 2023; 16(1): 345-3. doi: 10.52711/0974-360X.2023.00061
17.    Orisaka M, Mizutani T, Miyazaki Y, Shirafuji A, Tamamura C, Fujita M, Tsuyoshi H, Yoshida Y. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front Endocrinol (Lausanne). 2023; Dec 13; 14: 1324429. doi: 10.3389/fendo.2023.1324429.
18.    Iif Hanifa Nurrosyidah, Ni Made Mertaniasih, IsnaeniIsnaeni. Antibacterial Activity of Probiotics Cell-Free Fermentation Filtrate from Passiflora edulis Sims. againts Pathogen bacteria. Research Journal of Pharmacy and Technology 2022; 15(12): 5767-3. doi: 10.52711/0974-360X.2022.00973
19.    González F. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012; Mar 10; 77(4): 300-5. doi: 10.1016/j.steroids.2011.12.003.
20.    Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic Ovary Syndrome and Oxidative Stress-From Bench to Bedside. Int J Mol Sci. 2023; Sep 15; 24(18): 14126. doi: 10.3390/ijms241814126.
21.    Calcaterra V, Rossi V, Massini G, Casini F, Zuccotti G, Fabiano V. Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity. Nutrients. 2023; Jul 14; 15(14): 3144. doi: 10.3390/nu15143144.
22.    Le Barz M, Anhê FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A. Probiotics as Complementary Treatment for Metabolic Disorders. Diabetes Metab J. 2015; Aug; 39(4): 291-303. doi: 10.4093/dmj.2015.39.4.291.
23.    Wissam Zam, Reine Dawod. Overview of the Probiotics’ role in Gastrointestinal disorders. Research J. Pharm. and Tech. 2020; 13(11): 5557-5561. doi: 10.5958/0974-360X.2020.00970.1
24.    Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007; May 28; 13(20): 2826-32. doi: 10.3748/wjg.v13.i20.2826.
25.    Annette Babu, Ravichandran Veerasamy, Shalini Sivadasan. Metformin- A Drug of Plant Origin. Research J. Pharm. and Tech 2018; 11(6): 2701-2708. doi: 10.5958/0974-360X.2018.00499.7
26.    Markowiak-Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020; Apr 16; 12(4): 1107. doi: 10.3390/nu12041107.
27.    Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health. 2019; Sep 9; 13: 1179558119874042. doi: 10.1177/1179558119874042.
28.    K.V. Swathi. Probiotics –A Human Friendly Bacteria. Research J. Pharm. and Tech. 2016; 9(8): 1260-1262. doi: 10.5958/0974-360X.2016.00239.0
29.    Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016; May-Jun; 20(3): 324-8. doi: 10.4103/2230-8210.180005.
30.    Abhirup Dey, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal, Nilanjana Das. Isolation, Identification and In vitro Characterisation of Probiotic Yeast Strains. Research J. Pharm. and Tech. 2017; 10(3): 726-732. doi: 10.5958/0974-360X.2017.00136.6
31.    Den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J., and Bakker, B. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, 54(9), 2325–2340. https://doi.org/10.1194/jlr.R036012.
32.    James, M., Varghese, T. P., Sharma, R., and Chand, S. (2020). Association Between Metabolic Syndrome and Diabetes Mellitus According to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III Criteria: a Cross-sectional Study. Journal of diabetes and metabolic disorders, 19(1), 437–443. https://doi.org/10.1007/s40200-020-00523-2
33.    Md Kamal Hossain, Kamrun Nahar, Parisa Shokryazdan, Norhani Abdullah, Kaiser Hamid, Mohammed Faseleh Jahromi. Probiotic Potential of Lactic Acid Bacteria Isolated from Cheese, Yogurt and Poultry Faeces. Research J. Pharm. and Tech. 2017; 10(9): 2991-2998. doi: 10.5958/0974-360X.2017.00530.3.
34.    Wittich, C. M., Burkle, C. M., and Lanier, W. L. (2012). Ten common questions (and their answers) about off-label drug use. Mayo Clinic proceedings, 87(10), 982–990. https://doi.org/10.1016/j.mayocp.2012.04.017
35.    Wissam Zam, Reine Dawod. Overview of the Probiotics’ role in Gastrointestinal disorders. Research J. Pharm. and Tech. 2020; 13(11): 5557-5561. doi: 10.5958/0974-360X.2020.00970.1





Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available